PharmaCyte Biotech, Inc. Financial Ratios — PMCB Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-114.45	-114.15	-64.38	-447.04	-106.67	-73.69	-56.15	-90.57	-66.7	-64.05	-52.34	-8.65	-5.27	0.5	53.28
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.3	-32.49
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-11.58	-9.54
Gross Margin (%)	74.52	70.88	20.89	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	-275.94	-2,891.5	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	-308.23	-2,928.55	-13,851.65	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	- -	142,226.82	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	-1,109.32	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	-1,109.32	-2,853.62	-13,142.29	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	115.28	-3.83
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Total Debt	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
ST Debt	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	-6.82	-1.09	-0.25	- -	- -	- -	- -	- -	- -	-0.02	- -	- -	- -	- -	- -
Net Debt/EBITDA	-6.66	-1.08	-0.13	0.19	0.2	0.32	0.78	0.15	0.13	0.21	0.61	19.44	10.54	7.7	3.47
Total Debt/EBIT	-6.11	-1.07	-0.25	- -	- -	- -	- -	- -	- -	-0.02	- -	- -	- -	- -	- -
Net Debt/EBIT	-5.96	-1.07	-0.13	0.19	0.2	0.32	0.78	0.15	0.13	0.21	0.61	19.44	10.54	7.7	3.47
EBITDA to Interest Expense	-2.03	-7.98	-10.91	-901.49	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -
EBITDA-CapEx/Interest Expense	-2.03	-7.98	-15.1	-1,067.74	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -
EBIT to Interest Expense	-2.26	-8.08	-10.91	-901.49	- -	- -	- -	- -	- -	-8,446.79	-1,189.42	-8,628.71	- -	- -	- -
Interest Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Common Equity/Total Assets	-3,057.04	-1,906.88	-1,438.96	-736.7	-844.9	-1,181.7	-1,027.34	-1,494.85	-1,727.88	-1,684.19	-1,450.65	-123.2	-158.24	-193.01	-154.01
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.91	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-86.91	-123.09	-45.58	- -	- -	- -	- -	- -	- -	1.48	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-6.79	-5.63	-1.04	- -	- -	- -	- -	- -	- -	-0.07	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.27	100.23	14.6	- -	- -	- -	- -	- -	- -	1.22	- -	- -	- -	- -	- -
Net Debt to Equity	-84.82	-122.17	-23.95	-40.44	-34.71	-29.45	-42.84	-18.37	-10.22	-16.11	-32.97	-94.97	-93.6	-126.99	-29.24
Net Debt/Capital (%)	-6.61	-5.59	-0.54	5.01	3.32	2.22	3.74	1.09	0.51	0.78	2.01	43.34	36.98	32.6	15.15
EBITDA	- -	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4
EBITDA-CapEx	- -	-2	-2	-22	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4
Operating Income (Loss)	- -	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Cash Ratio	0.02	- -	0.05	9.68	1.78	3.01	5.97	1.65	0.69	0.87	3.04	121.24	115.99	6.76	5.33
Current Ratio	0.03	0.28	0.49	11.2	2.74	3.18	6.1	1.99	0.88	1.01	3.14	121.38	116.18	6.8	7.68
Quick Ratio	0.02	- -	0.05	9.68	1.78	3.01	5.97	1.65	0.69	0.87	3.04	121.24	115.99	6.76	6.6
CFO/Avg Current Liab	-0.07	-0.07	-0.1	-0.75	-4.82	-4.03	-5.48	-8.3	-4.15	-2.64	-3.79	-5.76	-5.88	-0.54	-0.58
Common Equity/Total Assets	-3,057.04	-1,906.88	-1,438.96	-736.7	-844.9	-1,181.7	-1,027.34	-1,494.85	-1,727.88	-1,684.19	-1,450.65	-123.2	-158.24	-193.01	-154.01
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.91	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	-0.04	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.75	- -	- -	- -	- -	- -
Total Debt/Equity (%)	-86.91	-123.09	-45.58	- -	- -	- -	- -	- -	- -	1.48	- -	- -	- -	- -	- -
Total Debt/Capital (%)	-6.79	-5.63	-1.04	- -	- -	- -	- -	- -	- -	-0.07	- -	- -	- -	- -	- -
Total Debt/Total Assets (%)	191.27	100.23	14.6	- -	- -	- -	- -	- -	- -	1.22	- -	- -	- -	- -	- -
CFO/Total Liabilities	-5.67	-6.85	-10.28	-416.07	-299.94	-681.64	-575.52	-788.52	-387.41	-216.98	-459.57	-584.54	-646.75	-10.55	-90.88
CFO/CapEx	- -	- -	-0.6	-0.44	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-46.95	-31.34	-16.1	258.77	18.36	12.22	43.85	-4.33	-31.16	-41.27	-8.74	30.01	56.74	-1.66	-0.39

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Accounts Receivable Turnover	19.76	27.18	9.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	18.47	13.43	38.74	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	3.02	1.52	2.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	120.71	240.58	129.87	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	0.07	0.01	0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	5,218.42	34,831.74	71,188.42	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	-5,079.24	-34,577.73	-71,019.81	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	-102.24	-227.16	-91.14	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Market Capitalization	- -	- -	43	178	113	53	68	54	47	34	40	36	57	20	9
- Cash & Cash Equivalents	- -	- -	- -	4	3	2	3	1	1	1	2	85	68	50	15
+ Preferred Equity and Hybrid Capital	1	1	1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	12	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	2	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	3	44	174	110	51	65	53	46	33	38	-49	-11	-18	-6
Total Capital	-35	-37	-40	-69	-79	-85	-89	-96	-100	-104	-107	-112	-116	-104	-85
Total Debt/Capital (%)	-6.79	-5.63	-1.04	- -	- -	- -	- -	- -	- -	-0.07	- -	- -	- -	- -	- -
Total Debt / EV	0.82	0.79	0.01	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	22.98	39.92	3,608.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Free Cash Flow to Firm	- -	- -	106.84	88.59	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Market Cap	- -	- -	43	178	113	53	68	54	47	34	40	36	57	20	9
Diluted Enterprise Value	3	3	44	174	110	51	65	53	46	33	38	-49	-11	-18	-6
EV per Share	12.39	10.63	149.2	447.8	234.65	102.35	114.61	82.06	62.85	37.06	25.91	- -	- -	- -	- -
TTM Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	- -	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4
TTM Operating Income	- -	-2	-2	-19	-13	-6	-4	-7	-4	-4	-4	-4	-6	-7	-4
TTM Cash Flow to Firm	- -	- -	- -	-2	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3
TTM Free Cash Flow to Firm	- -	- -	- -	2	-5	-4	-3	-5	-3	-2	-3	-4	-4	-2	-3

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	04/30/2011	04/30/2012	04/30/2013	04/30/2014	04/30/2015	04/30/2016	04/30/2017	04/30/2018	04/30/2019	04/30/2020	04/30/2021	04/30/2022	04/30/2023	04/30/2024	04/30/2025

Price/Free Cash Flow	- -	- -	168.08	91.41	-24.77	-12.26	-20.39	-10.65	-16.2	-14.68	-11.93	-8.78	-15	-9.44	-3.05
EV/EBIT	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	3	3	44	174	110	51	65	53	46	33	38	-49	-11	-18	-6
Low Price	- -	- -	38.75	143.38	147.25	59.67	35.65	46.81	55.8	36.42	6.2	1.79	1.95	1.92	1.03
EV/Sales	22.98	39.92	3,608.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.31
Price/Earnings Average	- -	- -	-14.76	-3.96	-15.29	-12.06	-14.44	-8.88	-14.97	-14.15	-9.94	-23.71	-12.15	-10.6	0.44
Price/Earnings High	- -	- -	-28.24	-13.72	-24.93	-21.49	-33.22	-13.93	-29.36	-25.26	-23.39	-103.29	-14	-14.17	0.6
Price/Earnings Low	- -	- -	-7.13	-2.05	-6.97	-4.94	-4.52	-4.43	-10.07	-8.6	-2.53	-6.55	-8.81	-8.42	0.26
Price/Book Value	- -	- -	-1.04	-2.59	-1.44	-0.63	-0.76	-0.56	-0.47	-0.33	-0.37	-0.32	-0.49	-0.18	-0.11
Price/Book Value Average	- -	- -	-0.57	-1.57	-1.93	-0.86	-0.72	-0.63	-0.61	-0.52	-0.33	-0.9	-0.45	-0.2	-0.15
Price/Book Value High	- -	- -	-1.09	-5.45	-3.15	-1.54	-1.66	-0.99	-1.2	-0.93	-0.77	-3.92	-0.52	-0.27	-0.21
Price/Book Value Low	- -	- -	-0.28	-0.81	-0.88	-0.35	-0.23	-0.32	-0.41	-0.32	-0.08	-0.25	-0.33	-0.16	-0.09
Price/Tangible Book Value	- -	- -	-28.69	32.97	26.71	17.92	15	24.37	31.29	22.29	12.69	0.42	0.82	0.78	0.18
Price/Tangible Book Value Average	- -	- -	-15.71	20.02	35.9	24.59	14.14	27.34	40.85	35.17	11.28	1.16	0.76	0.89	0.26
Price/Tangible Book Value High	- -	- -	-30.06	69.32	58.54	43.82	32.53	42.87	80.14	62.79	26.54	5.07	0.87	1.19	0.35
Price/Tangible Book Value Low	- -	- -	-7.59	10.34	16.36	10.07	4.43	13.63	27.48	21.38	2.87	0.32	0.55	0.7	0.15
Price/Sales	- -	- -	3,542.94	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	1,940.34	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	3,711.52	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	937.25	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	-110.35	-114.37	-24.77	-12.26	-20.39	-10.65	-16.2	-14.68	-11.93	-8.78	-15	-9.44	-3.05
Price/Cash Flow Average	- -	- -	-60.43	-69.44	-33.28	-16.82	-19.21	-11.94	-21.15	-23.16	-10.6	-24.41	-13.82	-10.75	-4.32
Price/Cash Flow High	- -	- -	-115.6	-240.45	-54.27	-29.98	-44.2	-18.73	-41.5	-41.34	-24.94	-106.35	-15.93	-14.38	-5.96
Price/Cash Flow Low	- -	- -	-29.19	-35.88	-15.17	-6.89	-6.02	-5.95	-14.23	-14.08	-2.7	-6.75	-10.02	-8.55	-2.53
Price/Free Cash Flow Average	- -	- -	92.05	55.49	-33.28	-16.82	-19.21	-11.94	-21.15	-23.16	-10.6	-24.41	-13.82	-10.75	-4.32
Price/Free Cash Flow High	- -	- -	176.07	192.17	-54.27	-29.98	-44.2	-18.73	-41.5	-41.34	-24.94	-106.35	-15.93	-14.38	-5.96
Price/Free Cash Flow Low	- -	- -	44.46	28.67	-15.17	-6.89	-6.02	-5.95	-14.23	-14.08	-2.7	-6.75	-10.02	-8.55	-2.53
EV/Sales Average	22.98	39.92	2,006.19	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	22.98	39.92	3,777.37	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	22.98	39.92	1,003.1	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-8.33	-1.38	-14.48	-5.5	-11.24	-11.72	-13.66	-8.54	-14.72	-13.94	-9.14	-3.44	2.42	2.33	0.53
EV/EBITDA High	-8.33	-1.38	-27.27	-19.51	-18.46	-21.14	-32.45	-13.48	-29	-25.05	-22.32	-80.25	1.18	1.13	-0.59
EV/EBITDA Low	-8.33	-1.38	-7.24	-2.75	-5.01	-4.61	-3.75	-4.18	-9.86	-8.39	-1.87	13.12	4.65	3.05	1.74
EV/EBIT Average	-7.45	-1.36	-14.48	-5.5	-11.24	-11.72	-13.66	-8.54	-14.72	-13.94	-9.14	-3.44	2.42	2.33	0.53
EV/EBIT High	-7.45	-1.36	-27.27	-19.51	-18.46	-21.14	-32.45	-13.48	-29	-25.05	-22.32	-80.25	1.18	1.13	-0.59
EV/EBIT Low	-7.45	-1.36	-7.24	-2.75	-5.01	-4.61	-3.75	-4.18	-9.86	-8.39	-1.87	13.12	4.65	3.05	1.74
Last Price	- -	- -	146.48	457.1	240.4	106.18	120.75	83.7	63.55	37.97	27.43	2.33	2.92	2.12	1.24
High Price	- -	- -	153.45	961	526.84	259.63	261.8	147.25	162.75	106.95	57.35	28.21	3.1	3.23	2.42
Enterprise Value Average	3	3	24	104	149	71	61	60	60	53	33	15	-16	-15	-2
Enterprise Value High	3	3	46	370	245	128	144	94	119	96	81	352	-8	-7	3
Enterprise Value Low	3	3	12	52	66	28	17	29	40	32	7	-58	-30	-20	-8

Shares Outstanding	- -	- -	- -	- -	- -	1	1	1	1	1	2	21	17	8	7
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	1	1	1	1	1	1	16	19	10	7
Revenue per Share	0.54	0.27	0.04	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-1.49	-7.7	-5.73	-48.79	-28.23	-12.1	-7.88	-10.81	-5.59	-4.23	-2.5	-0.28	-0.33	-0.68	-0.6
Operating Income per Share	-1.66	-7.8	-5.73	-48.79	-28.23	-12.1	-7.88	-10.81	-5.59	-4.23	-2.5	-0.28	-0.33	-0.68	-0.6
Basic EPS, GAAP	-5.98	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03
Basic EPS from Cont Ops	-5.98	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18
Diluted EPS, GAAP	-5.98	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	-0.23	4.03
Diluted EPS from Cont Ops	-5.98	-7.6	-5.43	-70.06	-21.13	-12.08	-7.88	-10.57	-5.54	-4.23	-2.45	-0.27	-0.22	0.03	4.18
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-0.96	-1.04	-1.33	-4	-9.71	-8.66	-5.92	-7.86	-3.92	-2.59	-2.3	-0.27	-0.19	-0.22	-0.41
Free Cash Flow per Basic Share	-0.96	-1.04	-3.53	-12.99	-9.71	-8.66	-5.92	-7.86	-3.92	-2.59	-2.3	-0.27	-0.19	-0.22	-0.41
Cash & Equivalents per Share	0.24	0.06	0.68	9.3	5.75	3.83	6.14	1.64	0.7	0.99	1.52	5.5	3.49	5.24	2.12
Book Value per Share	-162.24	-159.25	-140.75	-176.43	-167.21	-168.6	-157.93	-148.38	-136.16	-114.91	-74.16	-7.19	-5.95	-12.07	-11.59
Tangible Book Value per Share	-14.16	-9.12	-5.1	13.86	9	5.92	8.05	3.43	2.03	1.7	2.16	5.56	3.55	2.72	6.87

PharmaCyte Biotech, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)